The Journal of Diabetes and Metabolic Disorders has retracted a 2012 study by a group of Iranian researchers. The reason: the authors had published the paper three years earlier, in a different journal.
Here’s the notice for the article, titled “Mobile phone text messaging and Telephone follow-up in type 2 diabetic patients for 3 months: a comparative study”: Continue reading Mobile phone-diabetes study rings twice, earns retraction
The International Journal of Neuroscience has retracted a September 2005 paper by a group from Turkey who published the same article in the same month in a different journal.
The research involved looking at concentrations of blood fats in athletes and less vigorous folk, “and to examine the risks of cardiovascular diseases.”It found that:
… medium and high level of exercises did not cause significant differences in lipid and lipoprotein levels, but the sex differences were very pronounced” with “lipid and lipoprotein profile of female subjects was found to be better than that of males”.
Here’s the notice: Continue reading Double dipping on exercise/cardiac risk paper leads to retraction
On Tuesday, we reported on the case of Adam Savine, a former graduate student at Washington University in St. Louis who was found by the Office of Research Integrity (ORI) to have committed misconduct.
Today, Blythe Bernhard, of the St. Louis Post-Dispatch, has an illuminating Q and A with Todd Braver, whose lab Savine worked in. Savine’s former mentor offers a few interesting details about the investigation into his former student.
Braver tells the paper that he’d had doubts about the integrity of Savine’s data as the student was preparing for his dissertation defense in August 2012: Continue reading Wash U psychologist sheds light on inquiry against former psychology grad student
The Journal of Maternal-Fetal & Neonatal Medicine has retracted a 2008 article on smoking cessation by a group from Sweden which they had published not many months before in a different journal.
The retracted paper was titled “Quitting smoking is perceived to have an effect on somatic health among pregnant and non-pregnant women.” The authors, from the Royal Institute of Technology in Stockholm, had published a similar paper — “Perception of Smoking-Related Health Consequences among Pregnant and Non-Pregnant Women” — in the American Journal of Addictions in 2007.
How similar?
The Office of Research Integrity says Adam Savine, a former post-doc graduate student in psychology at Washington University in St. Louis, committed misconduct in work that tainted three papers and six abstracts he submitted to conferences.
One of Savine’s studies that drew some media attention involved Diederik Stapel-esque research showing which brain region lights up when people see money. He was quoted in this 2010 article on Medical News Today saying:
“We wanted to see what motivates us to pursue one goal in the world above all others,” Savine says. “You might think that these mechanisms would have been addressed a long time ago in psychology and neuroscience, but it’s not been until the advent of fMRI about 15-20 years ago that we’ve had the tools to address this question in humans, and any progress in this area has been very, very recent.”
Apparently, now we know. According to the notice, Savine engaged in misconduct in research funded by four grants: Continue reading Wash U psych researcher cited in ORI probe, faces multiple retractions
A group of Belgian researchers has retracted two decade-old papers in Arthritis & Rheumatism following an investigation and court case.
The papers involved the use of the drug infliximab — sold by Johnson & Johnson as Remicade — to treat Sjögren’s syndrome, an auto-immune condition marked by the destruction of exocrine glands that secrete saliva and tears.
Infliximab is not approved for Sjögren’s. Although the two now-retracted studies suggested that it might be helpful, subsequent data did not support those findings.
Neither, apparently, did the studies themselves. Here’s the retraction notice (it’s a PDF): Continue reading Authors retract two papers on Remicade following legal battles
A Saudi engineer has lost his 2012 paper in Renewable and Sustainable Energy Reviews for plagiarizing from two previously published articles, including one in the same journal.
The article, titled “Fresh water production from/by atmospheric air for arid regions, using solar energy: Review,” was written by A.M.K. El-Ghonemy, of Al-Jouf University.
According to the retraction notice:
Continue reading Fresh water paper proves recycled, gets retracted
A group of nutrition researchers at the University of California, Davis has retracted their paper in the International Journal of Molecular Sciences for what they describe as a botched experiment involving mixed-up cultures.
The article, titled “Dextran Sulfate Sodium Inhibits Alanine Synthesis in Caco-2 Cells,” appeared in 2011 and was retracted in February 2012, although it just came to our attention.
According to the abstract:
Continue reading Bowel cell paper falls to culture confusion
Hip International has retracted a case study for duplication. (We apologize for the partial duplication of a headline for an earlier post about this journal, which told readers that “Similar cases will be referred to retractionwatch.”)
The article was titled “Chronic intoxication with cobalt following revision total hip arthroplasty,” and it appeared online ahead of print. Cobalt toxicity associated with metal-on-metal replacement hips has been raised as a potential adverse effect from the devices.
As the notice explains:
The British Journal of Radiology has retracted a 2006 paper reporting a case study of an unusual primary cancer. Trouble is, their information was second-hand.
Here’s the notice for the article, titled “Primary extragonadal retroperitoneal teratoma in an adult”: Continue reading Primary tumor article retracted for, well, not being primary